Quantitative pharmacologic MRI: Mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice

NeuroImage

Volumn 55, Issue 2, 2011, Pages 622-628

  Perles Barbacaru, Teodora Adriana ^a   Procissi, Daniel ^a   Demyanenko, Andrey V ^a   Hall, F Scott ^b   Uhl, George R ^b   Jacobs, Russell E ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD VOLUME; BRAIN CORTEX; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; GENE DELETION; LIMBIC SYSTEM; MOUSE; NEUROMODULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REWARD; STIMULUS RESPONSE; WILD TYPE;

ANIMALS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 79551609331     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.12.048     Document Type: Article

References (53)

1. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with Image. J. Biophotonics Int. 2004, 11:36-42.
2. Berry I., Benderbous S., Ranjeva J.P., Gracia-Meavilla D., Manelfe C., Le Bihan D. Contribution of Sinerem used as blood-pool contrast agent: detection of cerebral blood volume changes during apnea in the rabbit. Magn. Reson. Med. 1996, 36:415-419.
3. Ceolin L., Schwarz A.J., Gozzi A., Reese T., Bifone A. Effects of cocaine on blood flow and oxygen metabolism in the rat brain: implications for phMRI. Magn. Reson. Imaging 2007, 25:795-800.
4. Chen Y.C., Mandeville J.B., Nguyen T.V., Talele A., Cavagna F., Jenkins B.G. Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents. J. Magn. Reson. Imaging 2001, 14:517-524.
5. Chin C.L., Fox G.B., Hradil V.P., Osinski M.A., McGaraughty S.P., Skoubis P.D., Cox B.F., Luo Y. Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesis. Neuroimage 2006, 33:1152-1160.
6. Choi J.K., Chen Y.I., Hamel E., Jenkins B.G. Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. Neuroimage 2006, 30:700-712.
7. Du C., Tully M., Volkow N.D., Schiffer W.K., Yu M., Luo Z., Koretsky A.P., Benveniste H. Differential effects of anesthetics on cocaine's pharmacokinetic and pharmacodynamic effects in brain. Eur. J. Neurosci. 2009, 30:1565-1575.
8. Du C., Yu M., Volkow N.D., Koretsky A.P., Fowler J.S., Benveniste H. Cocaine increases the intracellular calcium concentration in brain independently of its cerebrovascular effects. J. Neurosci. 2006, 26:11522-11531.
9. El-Ghundi M., O'Dowd B.F., George S.R. Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 2007, 18:37-66.
10. Gainetdinov R.R., Caron M.G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 2003, 43:261-284.
11. Girault J.A., Greengard P. The neurobiology of dopamine signaling. Arch. Neurol. 2004, 61:641-644.
12. Gozzi A., Ceolin L., Schwarz A., Reese T., Bertani S., Crestan V., Bifone A. A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI. Magn. Reson. Imaging 2007, 25:826-833.
13. Hall F.S., Li X.F., Randall-Thompson J., Sora I., Murphy D.L., Lesch K.P., Caron M., Uhl G.R. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 2009, 162:870-880.
14. Hall F.S., Li X.F., Sora I., Xu F., Caron M., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 2002, 115:153-161.
15. Jamshidi H.R., Rezayat M., Zarrindast M.R. Effect of apmin on tolerance to cocaine-induced locomotor activity in mice. Acta Med. Iran. 2004, 42:78-82.
16. Jenkins B.G., Sanchez-Pernaute R., Brownell A.-L., Chen Y.-C.I., Isacson O. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J. Neurosci. 2004, 24:9553-9560.
17. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 1989, 41:3-52.
18. Kaufman M.J., Levin J.M., Maas L.C., Rose S.L., Lukas S.E., Mendelson J.H., Cohen B.M., Renshaw P.F. Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study. Psychopharmacology 1998, 138:76-81.
19. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
20. Krimer L.S., Muly E.C., Williams G.V., Goldman-Rakic P.S. Dopaminergic regulation of cerebral cortical microcirculation. Nat. Neurosci. 1998, 1:286-289.
21. Leslie R.A., James M.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol. Sci. 2000, 21:314-318.
22. Li M.Y., Yan Q.S., Coffey L.L., Reith M.E.A. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 1996, 66:559-568.
23. Luo F., Seifert T.R., Edalji R., Loebbert R.W., Hradil V.P., Harlan J., Schmidt M., Nimmrich V., Cox B.F., Fox G.B. Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in mice. Neuroscience 2008, 155:263-269.
24. Luo F., Wu G., Li Z., Li S.J. Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain. Magn. Reson. Med. 2003, 49:264-270.
25. Luo Z., Yuan Z., Tully M., Pan Y., Du C. Quantification of cocaine-induced cortical blood flow changes using laser speckle contrast imaging and Doppler optical coherence tomography. Appl. Opt. 2009, 48:D247-255.
26. Lyons D., Friedman D.P., Nader M.A., Porrino L.J. Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J. Neurosci. 1996, 16:1230-1238.
27. Mandeville J.B., Ekstrom L., Marota J.J.A., Jenkins B.G., Vanduffel W. Contrast-enhanced fMRI of cocaine action in awake, non-human primate. Proceedings of the International Society for Magnetic Resonance in Medicine 2005.
28. Mandeville J.B., Jenkins B.G., Chen Y.C., Choi J.K., Kim Y.R., Belen D., Liu C., Kosofsky B.E., Marota J.J. Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4T. Magn. Reson. Med. 2004, 52:1272-1281.
29. Mandeville J.B., Marota J.J., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B.R., Weisskoff R.M. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 1998, 39:615-624.
30. Marota J.J., Mandeville J.B., Weisskoff R.M., Moskowitz M.A., Rosen B.R., Kosofsky B.E. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in Rat. Neuroimage 2000, 11:13-23.
31. Mateo Y., Budygin E.A., John C.E., Jones S.R. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc. Natl Acad. Sci. USA 2004, 101:372-377.
32. Mueggler T., Baumann D., Rausch M., Staufenbiel M., Rudin M. Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease. J. Neurosci. 2003, 23:8231-8236.
33. Peoples L.L., Gee F., Bibi R., West M.O. Phasic firing time locked to cocaine self-infusion and locomotion: dissociable firing patterns of single nucleus accumbens neurons in the rat. J. Neurosci. 1998, 18:7588-7598.
34. Perles-Barbacaru A.T., Procissi D., Demyanenko A.V., Jacobs R.E. Nonlinear model for preprocessing of cerebral blood volume weighted functional MRI data and for evaluating pharmacokinetic properties of USPIO. Proc. Intl. Soc. Mag. Reson. Med. 18th Annual Scientific Meeting, Stockholm (Sweden) 2010, 3550.
35. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1998, 1:132-137.
36. Sanchez-Pernaute R., Jenkins B.G., Choi J.K., Iris Chen Y.C., Isacson O. In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias. Neurobiol. Dis. 2007, 27:220-227.
37. Schmidt K.F., Febo M., Shen Q., Luo F., Sicard K.M., Ferris C.F., Stein E.A., Duong T.Q. Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacol. Berl 2006, 185:479-486.
38. Schwarz A.J., Gozzi A., Reese T., Bifone A. In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage 2007, 34:1627-1636.
39. Schwarz A.J., Gozzi A., Reese T., Heidbreder C.A., Bifone A. Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A. Magn. Reson. Imaging 2007, 25:811-820.
40. Schwarz A.J., Reese T., Gozzi A., Bifone A. Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course. Magn. Reson. Imaging 2003, 21:1191-1200.
41. Schwarz A.J., Zocchi A., Reese T., Gozzi A., Garzotti M., Varnier G., Curcuruto O., Sartori I., Girlanda E., Biscaro B., Crestan V., Bertani S., Heidbreder C., Bifone A. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage 2004, 23:296-304.
42. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., Yamamoto H., Yamamoto T., Lesch K.P., Murphy D.L., Hall F.S., Uhl G.R., Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 2004, 29:1790-1799.
43. Sigovan M., Boussel L., Sulaiman A., Sappey-Marinier D., Alsaid H., Desbleds-Mansard C., Ibarrola D., Gamondes D., Corot C., Lancelot E., Raynaud J.S., Vives V., Lacledere C., Violas X., Douek P.C., Canet-Soulas E. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 2009, 252:401-409.
44. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., Wichems C., Lesch K.P., Murphy D.L., Uhl G.R. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl Acad. Sci. USA 2001, 98:5300-5305.
45. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl Acad. Sci. USA 1998, 95:7699-7704.
46. Thanos P.K., Michaelides M., Benveniste H., Wang G.J., Volkow N.D. The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse 2008, 62:319-324.
47. Thomas M.J., Kalivas P.W., Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol. 2008, 154:327-342.
48. Thomsen M., Hall F.S., Uhl G.R., Caine S.B. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J. Neurosci. 2009, 29:1087-1092.
49. Uhl G.R., Hall F.S., Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 2002, 7:21-26.
50. Weissleder R., Elizondo G., Wittenberg J., Rabito C.A., Bengele H.H., Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990, 175:489-493.
51. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., Mazziotta J.C. Automated image registration: I. General methods and intrasubject, intramodality validation. J. Comput. Assist. Tomogr. 1998, 22:139-152.
52. Wu E.X., Tang H., Asai T., Yan S.D. Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice. Neurosci. Lett. 2004, 365:223-227.
53. Zocchi A., Conti G., Orzi F. Differential effects of cocaine on local cerebral glucose utilization in the mouse and in the rat. Neurosci. Lett. 2001, 306:177-180.